Effects of nasal continuous positive airway pressure therapy on partners' sexual lives

To assess sexual functioning in male and female partners before and after nasal continuous positive airway pressure (CPAP) therapy in men with obstructive sleep apnea (OSA). Twenty-one male patients with moderate to severe OSA and erectile dysfunction, and their female partner, were recruited into this prospective study. Males diagnosed with OSA were treated with nasal CPAP therapy for 12 weeks. Women were assessed for sexual functioning using the Female Sexual Function Index (FSFI), and for mood status using the Beck Depression Inventory (BDI), before and after their male partner underwent nasal CPAP therapy. Sexual functioning was assessed in men using the International Index of Erectile Function (IIEF), before and after nasal CPAP therapy. After nasal CPAP therapy for OSA in men, IIEF scores were significantly higher than pre-treatment scores. Total pre-and post-treatment IIEF scores (mean +/- standard deviation) were 50.28 +/- 15.88 and 65.42 +/- 7.47, respectively, P < 0.01. Pre- and post-treatment FSFI scores in women were 21.54 +/- 6.62 and 29.94 +/- 3.76, respectively, P < 0.01. Pre-and post-treatment BDI scores in women were 14.61 +/- 9.69 and 12.42 +/- 8.92, respectively, P < 0.01. Following treatment of men with OSA, our data indicate benefits for nasal CPAP therapy on sexual functioning in both the male and female partners. Moreover, our findings indicate that improved sexual function in women after their male partner underwent nasal CPAP also had psychological benefits.